| Black Cat Syndicate Limited (BC8) ORDINARY FULLY PAID |
Materials |
$619 |
Paulsens Gold Operation - Regional Opportunities
|
26 Jul 2024 8:58AM |
$0.345 |
$0.875 |
risen by
153.62%
|
|
| EBR Systems Inc (EBR) CDI 1:1 US PERSON PROHIBITED |
Health Care |
$463 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
26 Jul 2024 8:58AM |
$1.080 |
$1.080 |
fallen by
0%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- EBR Systems Inc. is advancing its regulatory and commercialization efforts, specifically aiming to submit the final module of its PMA application to the FDA in Q3 2024.
- Erik Strandberg was appointed as Chief Commercial Officer to lead the US commercialization strategy.
- EBR is targeting commercialization of its WiSE technology in the US by Q1 2025.
- EBR maintains strong cash reserves, holding US$54.1/A$81.11 million as of 30 June 2024.
- EBR's WiSE technology presented positive results at key US and European conferences.
- The company's activities are supported by its Breakthrough Device Designation, facilitating easier FDA and reimbursement processes.
- Q2 2024 reported net operating cash outflows of US$10.3 million, primarily due to staff costs, clinical, and regulatory expenses.
- EBR has an estimated funding availability covering 5.2 quarters, derived from current cash and short-term investments.
- Active engagement with investors and participation in clinical and investor conferences continues, such as attendance at the Bioshares Biotech Summit.
- The company released its 2023 Annual Report on 30 April 2024 and held its Annual Meeting of Stockholders on 30 May 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$62 |
Cleansing Notice under Section 708AA(2)(f)
|
26 Jul 2024 8:57AM |
$0.485 |
$0.550 |
risen by
13.40%
|
|
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$8 |
Quarterly Activities Report and Appendix 4C - June 2024
|
26 Jul 2024 8:57AM |
$0.069 |
$0.020 |
fallen by
71.01%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux launched Dapsone Gel, 5% in April 2024 for acne vulgaris.
- Three ANDAs are under FDA review.
- Secured $1.487 million from Radium Capital for R&D Tax Incentive.
- Positive cashflow reported in four of the past eight quarters.
- Financial performance includes significant expenditures on API purchases and R&D.
- FDA approvals and new product launches are expected to drive future revenue growth.
- Fifteen products are in Acrux's development portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$62 |
Proposed issue of securities - MVP
|
26 Jul 2024 8:57AM |
$0.485 |
$0.550 |
risen by
13.40%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$62 |
Appendix 4C & Quarterly Activity Report - 30 June 2024
|
26 Jul 2024 8:57AM |
$0.485 |
$0.550 |
risen by
13.40%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly sales of Penthrox in the Australian hospital segment.
- Record in-market demand for Penthrox in Europe, especially in the Nordic region, France, and the UK.
- Extension of Penthrox distribution agreement in the UK and Ireland until end of 2027 with improved economic terms.
- Significant business efficiency improvements implemented.
- Unaudited financial results for FY24 show a 5ppt increase in gross margin, $5 million reduction in operating costs, and improved underlying EBIT and free cashflow.
- Cash balance at 30 June 2024 stands at $9.7 million.
- Announced a fully underwritten capital raising of $10 million.
- Positive operating cashflow anticipated by the end of FY25.
- Revenue for Q4 FY24 was $9.5 million, totaling $33.2 million for the year.
- Pain Management revenue was $5.8 million for Q4 FY24 and $21.3 million for the year.
- Respiratory revenue amounted to $3.6 million for Q4 FY24 and $11.9 million for the year.
- Improved customer receipts, reduction in working capital, and better underlying cashflows improved cash use in Q4 FY24 to $0.4 million from $3.9 million in the prior quarter.
- Finalized Penthrox MAGPIE pediatric clinical study in Europe and prepared for regulatory submission to expand age indication.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$62 |
Investor Presentation - $10M Capital Raise
|
26 Jul 2024 8:56AM |
$0.485 |
$0.550 |
risen by
13.40%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Medical Developments International to raise $10 million through fully underwritten capital raising
- Funds will be used for targeted growth initiatives and working capital
- Offer comprises an institutional placement and a 1-for-7.35 pro-rata accelerated non-renounceable entitlement offer
- Approximately 26.3 million new shares to be issued at $0.38 per share
- Bell Potter Securities Limited is the sole lead manager and underwriter for the offer
- Offer price represents a 21.6% discount to the last close price on 25 July 2024
- Institutional entitlement offer opens on 26 July 2024 and retail entitlement offer from 2 August to 22 August 2024
- Capital raised will support the acceleration of Penthrox® growth through evidence generation, commercial investment, and operational efficiencies
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iltani Resources Limited (ILT) ORDINARY FULLY PAID |
Materials |
$11 |
ILT June 2024 Quarterly Activities Report & Appendix 5B
|
26 Jul 2024 8:56AM |
$0.200 |
$0.215 |
risen by
7.50%
|
|
ILT - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed 11-hole RC drilling program at Orient Silver-Indium Project.
- Intersected extensive silver-lead-zinc-indium mineralisation.
- Confirmed open pit mining potential at Orient West.
- Drilled a deep diamond hole funded by Queensland Department of Resources.
- Filed an exploration license application in Tasmania.
- Cash balance of A$2.38 million as of 30 June 2024.
- ASX releases detailing exploration activities and results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$62 |
MVP Announces $10M Capital Raise
|
26 Jul 2024 8:56AM |
$0.485 |
$0.550 |
risen by
13.40%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Medical Developments International Limited (MVP) announced a $10 million fully underwritten capital raising.
- The capital raise includes a $5.5 million placement to institutional investors and a $4.5 million pro rata non-renounceable entitlement offer.
- Proceeds will fund targeted investments in growth initiatives to accelerate Penthrox's growth in Australia and global markets.
- The offer includes issuing 26.3 million new fully paid ordinary shares representing approximately 30.5% of MVP’s existing shares.
- Placement shares will be issued at A$0.38 per share, which is a discount to the current share price.
- The Institutional Entitlement Offer and Retail Entitlement Offer divide the Entitlement Offer into components for institutional and retail shareholders respectively.
- MVP's FY24 unaudited results show a 3% increase in revenue and a $6.6 million improvement in Underlying EBIT.
- The company expects to achieve positive operating cashflow by the end of FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Archer Materials Limited (AXE) ORDINARY FULLY PAID |
Information Technology |
$69 |
Quarterly Activity Report & Appendix 4C
|
26 Jul 2024 8:55AM |
$0.285 |
$0.270 |
fallen by
5.26%
|
|
AXE - Price-sensitive ASX Announcement
Full Release
Key Points
- Improved accuracy and speed of reading quantum information using resonators.
- Achieved electron spin lifetimes up to 300 nanoseconds in new CNO films.
- Initiated ion-implantation experiments for enhanced quantum device fabrication.
- Developed a graphene transistor test procedure for gFET sensor performance.
- First six-inch wafer run for Archer’s Biochip gFET with a foundry partner in Spain.
- Miniaturised Biochip gFET design set for commercial fabrication in the Netherlands and assembly in Japan.
- Technologies showcased at WEF Global Technology and Advanced Manufacturing events.
- Appointed Dr. Simon Ruffell as Chief Technology Officer.
- Maintained a strong financial position with $18.2 million in cash and no debt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$76 |
Quarterly Cashflow Report - June 2024
|
26 Jul 2024 8:55AM |
$0.325 |
$0.328 |
risen by
0.77%
|
|
WTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities was $-734k for the quarter.
- Minimal receipts from interest income at $9k.
- Payments included $376k for exploration and $367k for administrative and corporate costs.
- Proceeds from investments were $123k.
- Funding activities included $3 million raised from equity securities.
- Cash and cash equivalents at the end of the quarter were $2.63 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$195 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
26 Jul 2024 8:54AM |
$0.595 |
$0.550 |
fallen by
7.56%
|
|
IMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed acquisition of Adeva Home Solutions (renamed Signature Security) in June 2024.
- Net operating cash flow for the quarter was +$3.7m.
- Integration of acquisitions expected to improve cash flow significantly in FY25.
- Company finished the year consistent with upgraded EBITDA guidance.
- Australian Commercial business continues strong growth.
- Capex for the quarter was $3.2m mainly for 3G conversions and growth in medical systems contracts.
- Retained Neu Capital to assist in refinancing $80m loan.
- Focused on delivering improved cash flow results and business improvements in FY25.
- Reported $25.5 million cash on hand as of 30 June 2024.
- Issued securities raised $19.3 million before costs for acquisitions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alicanto Minerals Limited (AQI) ORDINARY FULLY PAID |
Materials |
$27 |
Completion of Entitlement Offer
|
26 Jul 2024 8:53AM |
$0.025 |
$0.032 |
risen by
28%
|
|
| VIP Gloves Limited (VIP) ORDINARY FULLY PAID |
Health Care |
$2 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
26 Jul 2024 8:50AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$5 |
FY24 Q4 Quarterly Activities / Appendix 4C Cash Flow Report
|
26 Jul 2024 8:50AM |
$0.720 |
$0.070 |
fallen by
90.28%
|
|
BSA - Price-sensitive ASX Announcement
Full Release
Key Points
- Q4 FY2024 revenue achieved $68.4 million, increasing by 17.5% compared to Q4 FY2023.
- Full-year FY24 revenue was $255.5 million, an increase of 6.5% year-over-year.
- EBITDA for FY24 was $22.2 million, demonstrating a 37% improvement from FY23.
- The company renewed a 3-year contract with Foxtel, extending the partnership until 2027 with options for two additional years.
- Net debt reduced to $6.4 million as of June 30, 2024.
- Adjusted positive operating cash flow for Q4 FY24 was $2.7 million.
- No dividends were paid during the quarter.
- Received $8 million in new borrowings and repaid $6.5 million during the quarter.
- Joint CEOs foresee continued positive momentum into FY25 targeting double-digit EBITDA margins.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dreadnought Resources Ltd (DRE) ORDINARY FULLY PAID |
Materials |
$66 |
Consolidation, Growth & Commercialisation - Mangaroon Gold
|
26 Jul 2024 8:50AM |
$0.022 |
$0.013 |
fallen by
39.53%
|
|
DRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Dreadnought Resources Ltd announced a strategic acquisition of ~300km2 of highly prospective ground along the Mangaroon Shear Zone.
- An initial Exploration Target at the Star of Mangaroon deposit has been estimated using historical and recent drilling data.
- The Exploration Target is within an existing Mining Lease with minimal barriers to production.
- Potential quality and grade of the Exploration Target is conceptual; further exploration is needed to estimate a Resource.
- The internal study supports commercialization via outsourcing funding, development, haulage, and processing.
- Discussions are ongoing with Black Cat Syndicate Ltd regarding processing gold at Black Cat’s Paulsens Gold Operation.
- Dreadnought aims to extend their commercialization model to other opportunities along the Mangaroon Shear Zone.
- Dreadnought’s recent drilling at Star of Mangaroon has confirmed high-grade gold intersections and potential for underground development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$118 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
26 Jul 2024 8:50AM |
$0.375 |
$0.505 |
risen by
34.67%
|
|
AUE - Price-sensitive ASX Announcement
Full Release
Key Points
- 45,000m diamond drilling program continued with results from BD Targets hitting multiple +50 gold gram metre intercepts
- Significant results from Boundiali included intercepts with notable gold grades from various depths
- Aurum-owned fleet expanding to six diamond drill rigs with a capacity of ~10,000m per month by August 2024
- Planned initial Mineral Resource Estimate for Boundiali by late CY2024
- Preliminary metallurgical test work showed gold recoveries up to 99% from oxide samples
- Cash position at end of June 2024 was $10.8 million, with $9.46 million expected from the second tranche of a $17M capital raise
- Drilling more than 45,000 metres of diamond core targeted for CY2024
- Appointment of Mark Strizek as Executive Director and Fred N’Kanza as Country Manager for Côte d’Ivoire
- Strategic partnership to earn up to 70% interest in Boundiali North tenement
- General Meeting of Shareholders scheduled for 6 August 2024 to approve capital raise and other initiatives
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metro Mining Limited (MMI) ORDINARY FULLY PAID |
Materials |
$390 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
26 Jul 2024 8:50AM |
$0.047 |
$0.064 |
risen by
36.17%
|
|
MMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Metro Mining Limited's quarterly activities report for April-June 2024 presents key highlights.
- FOB prices increased by 13% in Q2 2024 compared to Q4 2023.
- Record shipments of 1.42 million wet metric tonnes in Q2, up 12% year-on-year (YoY).
- Final components of the 7 million WMT per annum expansion successfully commissioned.
- Successful $40 million placement and $5 million share purchase plan completed.
- Revised shipment guidance to 6.0 to 6.4 million WMT due to delays.
- Ikamba Offshore Floating Terminal and new screening circuit began operations.
- Gross CIF revenue improved in Q2 2024.
- Project forecast capital spending to be within the approved budget of $36.1 million.
- Appendix 5B cash flow report included, showing detailed financials including receipts, payments, and cash flows from various activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metals X Limited (MLX) ORDINARY FULLY PAID |
Materials |
$496 |
Quarterly Activities Report
|
26 Jul 2024 8:48AM |
$0.420 |
$0.560 |
risen by
33.33%
|
|
MLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Renison achieved a historic milestone with 1,061 tonnes of tin-in-concentrate produced in June 2024.
- The operation has surpassed 10,000 tonnes of tin-in-concentrate production on a 12-month rolling basis.
- Quarterly production was 2,506 tonnes, a 10.3% increase from Q1 CY2024.
- Mechanical repairs and processing issues in April and May were effectively addressed to achieve strong June performance.
- Mining costs increased due to additional development and processing costs rose due to higher reagent use.
- Financial performance saw an improvement with EBITDA increasing to $57.92 million from $35.41 million in Q1.
- AIC decreased to $33,769 per tonne of tin-in-concentrate from $34,116 in Q1.
- Capital expenditure for the quarter was $19.65 million focusing on ventilation upgrade, dewatering, and surface projects.
- Metals X invested in First Tin Plc, acquiring 60 million shares for $4.64 million, representing about 23% of outstanding shares.
- At quarter end, Metals X held $181.65 million in cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Purifloh Limited (PO3) ORDINARY FULLY PAID |
Utilities |
$7 |
Half Year Report FY24 and Appendix 4D
|
26 Jul 2024 8:46AM |
$0.220 |
$0.220 |
fallen by
0%
|
|
| Australian Vintage Ltd (AVG) ORDINARY FULLY PAID |
Consumer Staple |
$28 |
Final Director's Interest Notice - Naseema Sparks
|
26 Jul 2024 8:46AM |
$0.165 |
$0.086 |
fallen by
47.88%
|
|
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
26 Jul 2024 8:43AM |
$2.860 |
$2.590 |
fallen by
9.44%
|
|
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$150 |
Notice of Annual General Meeting
|
26 Jul 2024 8:43AM |
$0.720 |
$0.845 |
risen by
17.36%
|
|
| 88 Energy Limited (88E) ORDINARY FULLY PAID |
Energy |
$28 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
26 Jul 2024 8:43AM |
$0.003 |
$0.024 |
risen by
700%
|
|
88E - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful oil flow tests at Project Phoenix.
- Planning for a horizontal flow test and farm-out process.
- Completion of prospective resource estimate for Project Leonis.
- Planning for Tiri-1 exploration well.
- Cash balance of A$7.9 million as at 30 June 2024.
- A$9.9 million raised through oversubscribed share placement.
- A$17.3 million spent on exploration and evaluation, mainly for the Hickory-1 flow test.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$211 |
Quarterly Activities Report
|
26 Jul 2024 8:43AM |
$0.390 |
$0.285 |
fallen by
26.92%
|
|
FEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Seven iron ore shipments completed from Iron Ridge totalling 400,627 wmt
- C1 Cash Costs for Iron Ridge maintained at A$79.7/wmt
- Net average C1 operating margin for Iron Ridge of A$65/dmt
- Shine Iron Ore Mine recommissioning commenced
- Beebyn-W11 Iron Ore Mine to commence in early 2025
- Ruvidini Inland Port terminal substantially complete
- Annual shipping run rate achieved nearly 4Mtpa; total volumes shipped 978,753 tonnes
- Cash balance of A$77.4 million as of 30 June 2024
- Significant growth projects include Ruvidini Inland Port and recommencement of Shine Iron Ore Mine
- Key appointments: Ms Shannon Coates as Non-Executive Director and Ms Natalie Teo as Company Secretary
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
